Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$415M |
| 2 |
Tesla
TSLA
|
+$360M |
| 3 |
Capital One
COF
|
+$328M |
| 4 |
Johnson & Johnson
JNJ
|
+$168M |
| 5 |
EMA
Emera Incorporated
EMA
|
+$164M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$1.14B |
| 2 |
Apple
AAPL
|
+$1.03B |
| 3 |
DFS
Discover Financial Services
DFS
|
+$296M |
| 4 |
Eli Lilly
LLY
|
+$215M |
| 5 |
Amazon
AMZN
|
+$205M |
Sector Composition
| 1 | Technology | 34.3% |
| 2 | Financials | 13.54% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Healthcare | 9.2% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Celldex Therapeutics
CLDX
$1.62B
| $1.45M | ﹤0.01% |
71,190
+7,049
| +11% | +$143K |
|
2102
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.4B
| $1.45M | ﹤0.01% |
27,433
+3,411
| +14% | +$180K |
|
|
HNGE
2103
Hinge Health, Inc.
HNGE
$4.52B
| $1.45M | ﹤0.01% |
+27,917
| New | +$1.45M |
|
2104
Phibro Animal Health
PAHC
$1.61B
| $1.44M | ﹤0.01% |
56,549
+2,693
| +5% | +$68.8K |
|
|
UHT
2105
Universal Health Realty Income Trust
UHT
$575M
| $1.44M | ﹤0.01% |
36,114
+2,025
| +6% | +$80.9K |
|
2106
Tarsus Pharmaceuticals
TARS
$2.08B
| $1.44M | ﹤0.01% |
35,426
+7,832
| +28% | +$317K |
|
2107
Forward Air
FWRD
$904M
| $1.43M | ﹤0.01% |
58,385
+4,436
| +8% | +$109K |
|
2108
Reynolds Consumer Products
REYN
$4.84B
| $1.43M | ﹤0.01% |
66,654
+4,205
| +7% | +$90.1K |
|
2109
Asana
ASAN
$3.12B
| $1.43M | ﹤0.01% |
105,685
+11,185
| +12% | +$151K |
|
2110
Cipher Mining
CIFR
$4.27B
| $1.43M | ﹤0.01% |
298,446
+74,744
| +33% | +$357K |
|
2111
IMAX
IMAX
$1.74B
| $1.43M | ﹤0.01% |
50,969
+756
| +2% | +$21.1K |
|
2112
Xencor
XNCR
$613M
| $1.42M | ﹤0.01% |
180,905
-2,722
| -1% | -$21.4K |
|
2113
CEVA Inc
CEVA
$564M
| $1.42M | ﹤0.01% |
64,654
+3,479
| +6% | +$76.5K |
|
2114
TriCo Bancshares
TCBK
$1.48B
| $1.42M | ﹤0.01% |
34,999
+1,420
| +4% | +$57.5K |
|
2115
Vermilion Energy
VET
$1.14B
| $1.42M | ﹤0.01% |
194,266
+13,086
| +7% | +$95.3K |
|
2116
Turning Point Brands
TPB
$1.84B
| $1.41M | ﹤0.01% |
18,674
+1,202
| +7% | +$91.1K |
|
2117
Lionsgate Studios Corp.
LION
$2.13B
| $1.41M | ﹤0.01% |
+243,311
| New | +$1.41M |
|
|
GRRR
2118
Gorilla Technology Group
GRRR
$411M
| $1.41M | ﹤0.01% |
+71,064
| New | +$1.41M |
|
2119
NovaGold Resources
NG
$2.82B
| $1.41M | ﹤0.01% |
343,948
+96,351
| +39% | +$395K |
|
|
INN
2120
Summit Hotel Properties
INN
$623M
| $1.41M | ﹤0.01% |
277,113
-411,055
| -60% | -$2.09M |
|
2121
BrightView Holdings
BV
$1.32B
| $1.41M | ﹤0.01% |
84,649
+28,247
| +50% | +$470K |
|
2122
Coursera
COUR
$1.8B
| $1.41M | ﹤0.01% |
160,742
-9,170
| -5% | -$80.3K |
|
2123
Sable Offshore Corp
SOC
$2.3B
| $1.4M | ﹤0.01% |
63,788
+13,974
| +28% | +$307K |
|
2124
Delek US
DK
$1.68B
| $1.4M | ﹤0.01% |
66,111
-13,341
| -17% | -$283K |
|
2125
Biohaven
BHVN
$1.47B
| $1.39M | ﹤0.01% |
98,516
+3,152
| +3% | +$44.5K |
|